Clinical Trials Browser

Phase 2 × Myeloproliferative Disorders × Interferon alpha-2 × Clear all

NCT00452023 2024-12-11

Pegasys® in Patients With Myeloproliferative Diseases

Phase 2 Completed

83 enrolled 12 charts

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential